Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Larson

Showing results (31-40 of 383) with videos related to

Pageof 39
Sort By:
Best Practice & Research. Clinical Haematology|February 11, 2014
The evolving challenge of therapy-related myeloid neoplasmsJane E Churpek, Richard A Larson
Best Practice & Research. Clinical Haematology|March 6, 2003
Acute lymphoblastic leukaemia: diagnosis and classificationPartow Kebriaei, John Anastasi, Richard A Larson
Chemico-Biological Interactions|June 7, 2005
Therapy-related myeloid leukaemia: a model for leukemogenesis in humansRichard A Larson, Michelle M Le Beau
Mediterranean Journal of Hematology and Infectious Diseases|August 27, 2011
Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy-related myeloid neoplasmRichard A Larson, Michelle M Le Beau
Hemasphere|February 3, 2025
Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapiesUwe Platzbecker, Richard A Larson, Sandeep Gurbuxani
The New England Journal of Medicine|November 9, 2017
Midostaurin in FLT3-Mutated Acute Myeloid LeukemiaRichard M Stone, Richard A Larson, Hartmut Döhner
Current Hematologic Malignancy Reports|July 25, 2023
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/LymphomaAdam S DuVall, Austin Wesevich, Richard A Larson
Retina (Philadelphia, Pa.)|November 30, 2007
Chronic lymphocytic leukemia masquerading as uveitisGaurav Gupta, Richard A Larson, Lee M Jampol
Journal of Cancer Research and Clinical Oncology|April 22, 2021
Economics influences therapy decisions in chronic myeloid leukaemia: should it?Qian Jiang, Richard A Larson, Robert Peter Gale
Annals of Hematology|March 28, 2015
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EURena M Conti, William V Padula, Richard A Larson
Pageof 39

Showing results (31-40 of 383) with videos related to

Sort By:
Pageof 39
Best Practice & Research. Clinical Haematology|February 11, 2014
The evolving challenge of therapy-related myeloid neoplasmsJane E Churpek, Richard A Larson
Best Practice & Research. Clinical Haematology|March 6, 2003
Acute lymphoblastic leukaemia: diagnosis and classificationPartow Kebriaei, John Anastasi, Richard A Larson
Chemico-Biological Interactions|June 7, 2005
Therapy-related myeloid leukaemia: a model for leukemogenesis in humansRichard A Larson, Michelle M Le Beau
Mediterranean Journal of Hematology and Infectious Diseases|August 27, 2011
Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy-related myeloid neoplasmRichard A Larson, Michelle M Le Beau
Hemasphere|February 3, 2025
Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapiesUwe Platzbecker, Richard A Larson, Sandeep Gurbuxani
The New England Journal of Medicine|November 9, 2017
Midostaurin in FLT3-Mutated Acute Myeloid LeukemiaRichard M Stone, Richard A Larson, Hartmut Döhner
Current Hematologic Malignancy Reports|July 25, 2023
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/LymphomaAdam S DuVall, Austin Wesevich, Richard A Larson
Retina (Philadelphia, Pa.)|November 30, 2007
Chronic lymphocytic leukemia masquerading as uveitisGaurav Gupta, Richard A Larson, Lee M Jampol
Journal of Cancer Research and Clinical Oncology|April 22, 2021
Economics influences therapy decisions in chronic myeloid leukaemia: should it?Qian Jiang, Richard A Larson, Robert Peter Gale
Annals of Hematology|March 28, 2015
Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EURena M Conti, William V Padula, Richard A Larson
Pageof 39